The positive expression rate of maspin in benign tumors was 55.56% (5/9) while the rate in ovarian cancer was 52.38% (11/21), there was no significant difference between the two groups (Figure 1E, F). This evidence concerns the gene SERPINB5 and benign neoplasm.